Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Euroapi S.A. (EAPI.PA)
EUR1.29
+0.01 (+0.78%)
FR PAR Healthcare Medical - Devices
Address
15 Rue Traversiere 75012
Paris, FR
Paris, FR
CEO
David Seignolle
Website
euroapi.com/en
IPO
2022-05-06
ISIN FR0014008VX5
Also trades on
Euronext Paris · EAPI.PA (EUR)
Other OTC · EAPIF (USD)
Description
Headquartered in Paris, France, Euroapi SA, founded in 2021, specializes in the research, production, promotion, and delivery of active pharmaceutical ingredients (APIs) and chemical intermediates. These vital components are utilized in the development of both human and animal medical treatments.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR1.29
+0.01 (+0.78%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
151.0K
Beta
0.98
Float Shares
50.46M
Free Float %
53.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.33% | -0.80% | +8.61% | -30.79% | -52.46% | -34.45% | -50.23% | -84.98% | -88.99% | -88.99% | -88.99% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.29
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 2 | -1 |
| Sell | 2 | 0 |
| Strong Sell | 1 | 0 |
Quality scores
Altman Z-Score
0.21
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-7.7% Q4'25: -16.5% (vs Q4'23)
-
EPS growth Medical - Devices: +28.5%-61.6% Q4'25: +27.4% (vs Q4'23)
-
FCF margin FCF growth · Medical - Devices: +30.9%+11.7% ★ Q4'25: +15.5% (vs Q4'23)
-
EBIT margin Medical - Devices: +6.2%+0.2% Q4'25: -1.9% (vs Q4'23)
-
ROIC Medical - Devices: +3.3%+0.2% Q4'25: -4.4% (vs Q4'23)
-
Share dilution Medical - Devices: 0.0%+0.2% Q4'25: -0.1% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.46× Q4'25: 0.16× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
980.90M
est: 977.72M (+0.3%)
|
1.02B
est: 971.30M (+4.9%)
|
919.20M
est: 916.18M (+0.3%)
|
848.20M
est: 862.43M (-1.6%)
|
760.55M
748.58M – 770.08M
-11.8% YoY
|
781.49M
732.81M – 870.41M
+2.8% YoY
|
805.02M
789.05M – 820.99M
+3.0% YoY
|
868.10M
833.67M – 924.17M
+7.8% YoY
|
911.00M
874.86M – 969.84M
+4.9% YoY
|
| EBITDA |
120.20M
est: 55.49M (+116.6%)
|
71.00M
est: 76.18M (-6.8%)
|
-34.70M
est: 71.85M (-148.3%)
|
142.30M
est: 67.64M (+110.4%)
|
59.65M
58.71M – 60.39M
-11.8% YoY
|
61.29M
57.47M – 68.26M
+2.8% YoY
|
63.13M
61.88M – 64.39M
+3.0% YoY
|
68.08M
65.38M – 72.48M
+7.8% YoY
|
71.45M
68.61M – 76.06M
+4.9% YoY
|
| EBIT |
4.80M
est: -66.23M (+107.2%)
|
-231.90M
est: -65.23M (-255.5%)
|
-111.50M
est: -61.53M (-81.2%)
|
1.80M
est: -57.92M (+103.1%)
|
-51.08M
-51.72M – -50.28M
+11.8% YoY
|
-52.49M
-58.46M – -49.22M
-2.8% YoY
|
-54.07M
-55.14M – -52.99M
-3.0% YoY
|
-58.30M
-62.07M – -55.99M
-7.8% YoY
|
-61.18M
-65.14M – -58.76M
-4.9% YoY
|
| Net Income |
-15.00M
est: 38.29M (-139.2%)
|
-189.70M
est: -287.30M (+34.0%)
|
-130.60M
est: -54.15M (-141.2%)
|
-211.20M
est: -33.97M (-521.7%)
|
-49.94M
-69.58M – -30.30M
-47.0% YoY
|
-40.25M
-75.75M – 26.00M
+19.4% YoY
|
11.41M
742.0K – 14.46M
+128.4% YoY
|
6.88M
6.52M – 7.46M
-39.7% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
128.20M
est: 111.68M (+14.8%)
|
130.90M
est: 123.16M (+6.3%)
|
127.00M
est: 116.17M (+9.3%)
|
115.80M
est: 109.35M (+5.9%)
|
96.44M
94.92M – 97.64M
-11.8% YoY
|
99.09M
92.92M – 110.37M
+2.8% YoY
|
102.08M
100.05M – 104.10M
+3.0% YoY
|
110.07M
105.71M – 117.18M
+7.8% YoY
|
115.51M
110.93M – 122.97M
+4.9% YoY
|
| EPS |
-0.16
est: 0.41 (-139.4%)
|
-2.01
est: -3.04 (+34.0%)
|
-1.38
est: -0.56 (-145.2%)
|
-2.23
est: -0.33 (-571.2%)
|
-0.53
-0.73 – -0.32
-58.7% YoY
|
-0.22
-0.80 – 0.27
+57.7% YoY
|
0.06
0.01 – 0.15
+127.7% YoY
|
0.07
0.07 – 0.08
+17.6% YoY
|
—
— – —
-100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-80.68M
OE per share TTM
-0.85
Owner's Yield
-57.17%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
60.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 6 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Value ETF AVDV | 0.00% | 925.6K | 0.36% |
| 2 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.00% | 30.9K | 0.39% |
| 3 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 88.2K | 0.22% |
| 4 | Avantis International Equity ETF AVDE | 0.00% | 101.5K | 0.23% |
| 5 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 1.3K | 0.30% |
| 6 | Avantis Responsible International Equity ETF AVSD | 0.00% | 1.5K | 0.23% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
565.00
Shares Outstanding
95.19M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| David Seignolle | Chief Executive Officer | 971.0K | male |
| Emmanuel Mazeaud | Chief Digital Officer | — | male |
| Frederic Lelievre | Chief Quality Officer | — | male |
| Frederic Robert | Chief Commercial Officer | — | male |
| Jean-Francois Blanc | Chief Operating Officer | — | male |
| Laurence Bollack | Head of Global Media Relations | — | — |
| Marion Santin | Chief Legal, Compliance, & IP Officer | — | female |
| Olivier Falut | Chief Financial Officer | — | male |
| Raphaele Hauzy | Chief People Officer | — | female |
| Sophie Palliez | Head of Investor Relations | — | — |
| Sylvia Cabrillac-Rives | Chief Strategy Officer | — | female |
| Vincent Touraille | Chief Strategy and M&A Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EAPI.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
